Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y James Kang

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Cardiovascular Toxicology|July 27, 2007
Antioxidant defense against anthracycline cardiotoxicity by metallothioneinY James Kang
Pharmacology & Therapeutics|December 7, 2010
Copper and homocysteine in cardiovascular diseasesY James Kang
Experimental Biology and Medicine (Maywood, N.J.)|October 5, 2006
Metallothionein redox cycle and functionY James Kang
Current Opinion in Drug Discovery & Development|March 5, 2003
New understanding in cardiotoxicityY James Kang
Toxicologic Pathology|March 2, 2006
Cardiac hypertrophy: a risk factor for QT-prolongation and cardiac sudden deathY James Kang
Experimental Biology and Medicine (Maywood, N.J.)|June 7, 2008
Herbogenomics: from traditional Chinese medicine to novel therapeuticsY James Kang
Experimental Biology and Medicine (Maywood, N.J.)|August 23, 2002
Prior increase in metallothionein levels is required to prevent doxorubicin cardiotoxicityXiuhua Sun, Y James Kang
Molecular Aspects of Medicine|August 16, 2005
Zinc prevention and treatment of alcoholic liver diseaseY James Kang, Zhanxiang Zhou
Cardiovascular Toxicology|May 31, 2012
Ischemia-induced copper loss and suppression of angiogenesis in the pathogenesis of myocardial infarctionWeihong He, Y James Kang
Regenerative Medicine Research|May 19, 2015
Rejuvenation: an integrated approach to regenerative medicineY James Kang, Lily Zheng
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Cardiovascular Toxicology|July 27, 2007
Antioxidant defense against anthracycline cardiotoxicity by metallothioneinY James Kang
Pharmacology & Therapeutics|December 7, 2010
Copper and homocysteine in cardiovascular diseasesY James Kang
Experimental Biology and Medicine (Maywood, N.J.)|October 5, 2006
Metallothionein redox cycle and functionY James Kang
Current Opinion in Drug Discovery & Development|March 5, 2003
New understanding in cardiotoxicityY James Kang
Toxicologic Pathology|March 2, 2006
Cardiac hypertrophy: a risk factor for QT-prolongation and cardiac sudden deathY James Kang
Experimental Biology and Medicine (Maywood, N.J.)|June 7, 2008
Herbogenomics: from traditional Chinese medicine to novel therapeuticsY James Kang
Experimental Biology and Medicine (Maywood, N.J.)|August 23, 2002
Prior increase in metallothionein levels is required to prevent doxorubicin cardiotoxicityXiuhua Sun, Y James Kang
Molecular Aspects of Medicine|August 16, 2005
Zinc prevention and treatment of alcoholic liver diseaseY James Kang, Zhanxiang Zhou
Cardiovascular Toxicology|May 31, 2012
Ischemia-induced copper loss and suppression of angiogenesis in the pathogenesis of myocardial infarctionWeihong He, Y James Kang
Regenerative Medicine Research|May 19, 2015
Rejuvenation: an integrated approach to regenerative medicineY James Kang, Lily Zheng
Pageof 16